NASDAQ:BIOT

Biotech Acquisition Stock Forecast, Price & News

$9.84
+0.02 (+0.20 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$9.82
Now: $9.84
$9.90
50-Day Range N/A
52-Week Range
$9.54
Now: $9.84
$9.95
Volume634 shs
Average Volume63,878 shs
Market Capitalization$282.90 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Biotech Acquisition Company is a blank check company. The company was incorporated in 2020 and is based in New York, New York.

Industry, Sector and Symbol

Industry Shell Companies
Sub-IndustryN/A
Current SymbolNASDAQ:BIOT
CUSIPN/A
CIKN/A
WebN/A
Phone212 227 1905
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$282.90 million
Next Earnings DateN/A
OptionableNot Optionable

Headlines

See More Headlines

MarketRank

Overall MarketRank

0.00 out of 5 stars

Financial Services Sector

590th out of 808 stocks

Shell Companies Industry

212th out of 418 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$9.84
+0.02 (+0.20 %)
(As of 04/16/2021 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BIOT News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Biotech Acquisition (NASDAQ:BIOT) Frequently Asked Questions

What stocks does MarketBeat like better than Biotech Acquisition?

Wall Street analysts have given Biotech Acquisition a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Biotech Acquisition wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Biotech Acquisition's key executives?

Biotech Acquisition's management team includes the following people:
  • Dr. Michael Shleifer Ph.D., Chairman & CEO (Age 47)
  • Mr. Thomas Fratacci, CFO & Treasurer (Age 43)
  • Mr. Ivan Jarry, Chief Operating Officer (Age 43)
  • Mr. Albert F. Hummel M.B.A., Chief Investment Officer & Director (Age 75)

Who are some of Biotech Acquisition's key competitors?

What is Biotech Acquisition's stock symbol?

Biotech Acquisition trades on the NASDAQ under the ticker symbol "BIOT."

How do I buy shares of Biotech Acquisition?

Shares of BIOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Biotech Acquisition's stock price today?

One share of BIOT stock can currently be purchased for approximately $9.84.

How much money does Biotech Acquisition make?

Biotech Acquisition has a market capitalization of $282.90 million.

How can I contact Biotech Acquisition?

The company can be reached via phone at 212 227 1905.


This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.